alpha-chymotrypsin and Ischemia

For many years, the classification of chronic pancreatitis has been oversimplified according to whether the cause is alcoholic (60-70% of cases according to published series) or non-alcoholic (20-40% of the remaining cases). Recognition of smoking as an important risk factor and increasing identification of factors of genetic susceptibility have placed these percentages in doubt and have led to a reconceptualization of the disease as a multifactorial process. Mutations in the PRSS1, SPINK1 and CFTR genes have been confirmed as major risk factors, while mutations in the CTRC and CASR genes are considered lesser risk factors for the development of chronic pancreatitis. These genetic variants are expressed in a much higher percentage of patients with chronic pancreatitis than could be expected by chance. The trans-heterozygous combination multiplies the risk of chronic pancreatitis and demonstrates the degree of complexity of the etiopathogenic mechanisms of the disease. Ductal obstruction and autoimmunity are other important etiologic factors of chronic pancreatitis that need a specific review. The present article reviews the latest studies evaluating the role of alcohol and smoking in chronic pancreatitis and the most significant genetic factors.

Topics: Autoimmune Diseases; Carrier Proteins; Cholestasis; Chymotrypsin; Cystic Fibrosis Transmembrane Conductance Regulator; Duodenal Obstruction; Genetic Predisposition to Disease; Humans; Ischemia; Kidney Failure, Chronic; Mutation; Pancreas; Pancreatitis, Alcoholic; Pancreatitis, Chronic; Radiation Injuries; Receptors, Calcium-Sensing; Risk Factors; Smoking; Trypsin; Trypsin Inhibitor, Kazal Pancreatic

Intestinal ischemia is associated with high morbidity and mortality, but the underlying mechanisms are uncertain. We hypothesize that during ischemia the intestinal mucosal barrier becomes disrupted, allowing digestive enzymes access into the intestinal wall initiating autodigestion. We used a rat model of splanchnic ischemia by occlusion of the superior mesenteric and celiac arteries up to 30 min with and without luminal injection of tranexamic acid as a trypsin inhibitor. We determined the location and activity of digestive proteases on intestinal sections with in situ zymography, and we examined the disruption of two components of the mucosal barrier: mucin isoforms and the extracellular and intracellular domains of E cadherin with immunohistochemistry and Western blot techniques. The results indicate that nonischemic intestine has low levels of protease activity in its wall. After 15-min ischemia, protease activity was visible at the tip of the villi, and after 30 min, enhanced activity was seen across the full thickness of the intestinal wall. This activity was accompanied by disruption of the mucin layer and loss of both intracellular and extracellular domains of E cadherin. Digestive protease inhibition in the intestinal lumen with tranexamic acid reduced morphological damage and entry of digestive enzymes into the intestinal wall. This study demonstrates that disruption of the mucosal epithelial barrier within minutes of intestinal ischemia allows entry of fully activated pancreatic digestive proteases across the intestinal barrier triggering autodigestion.

Topics: Animals; Cadherins; Celiac Artery; Chymotrypsin; Constriction, Pathologic; Intestinal Mucosa; Intestines; Ischemia; Male; Mesenteric Arteries; Mucins; Pancreatic Elastase; Protease Inhibitors; Rats; Rats, Wistar; Splanchnic Circulation; Tranexamic Acid; Trypsin

Recent evidence indicates that shock is accompanied by a failure of the mucosal barrier in the intestine and entry of pancreatic digestive enzymes into the wall of the intestine. To investigate the formation of cytotoxic mediators produced by enzymatic digestion of the intestine, we applied homogenates of rat small intestinal wall to human neutrophils and used flow cytometry measurements of propidium iodide uptake to determine cytotoxicity. We show that homogenates of the small intestine after ischemia by occlusion of the superior mesenteric and celiac arteries for 3 h, but not without ischemia, are cytotoxic. Digestion of homogenates of nonischemic intestinal wall with purified trypsin, chymotrypsin, or elastase, proteases normally present in the intestinal lumen, yielded cytotoxic mediators. Before cell death, we saw cell damage in the form of bleb formation and flow cytometry measurements of cell size changes due to blebbing. Cytotoxicity was prevented by serine protease inhibition with phenylmethylsulfonyl fluoride (PMSF) before, but not after proteolytic digestion of the wall homogenates, indicating that enzymatic action of proteases on the homogenate is necessary for cytotoxicity. Cytotoxicity of wall homogenates digested by enzymes in the fluid collected from the lumen of the intestine was greater than digests by the individual purified proteases. Cytotoxicity is undetectable if digestive enzymes in the luminal fluid are inhibited with a combination of enzyme inhibitors PMSF and 6-amidino-2-naphthyl p-guanidinobenzoate dimethanesulfonate before addition of wall homogenates. Passage of digested intestinal wall homogenates across a hydrophobic glass-fiber filter reduced cytotoxicity. Furthermore, we found that luminal fluid itself may be cytotoxic, possibly because of digestion of ingested food. To test whether digested food can be cytotoxic, we homogenized rat food and digested it in vitro with chymotrypsin or endogenous enzymes in luminal fluid. Cytotoxicity was significantly increased after digestion of food by luminal fluid compared with luminal fluid or undigested food. These results indicate the presence of a previously unknown mechanism for hemorrhagic necrosis in shock.

Topics: Animals; Apoptosis; Chymotrypsin; Cytotoxins; Flow Cytometry; Humans; Inflammation; Intestines; Ischemia; Male; Neutrophils; Pancreas; Rats; Rats, Wistar; Shock

Increased intraperitoneal pressure in the head-down position is associated with a significant increase in intraocular pressure (IOP) in rabbits with alpha-chymotrypsin-induced glaucoma. Also, the retinal cells are weakened by the induction of increased IOP, and/or glaucoma, even when IOP is controlled by adequate therapy; therefore, these cells need to be protected from any additional aggression. Actin and vimentin are proteins of the retinal cell cytoskeleton that react readily in response to retinal injuries, including ischemia and glaucoma. Early changes in these cytoskeleton proteins determine the morphological changes observed after retinal damage. Therefore, we set out to investigate intracytoplasmic changes in vimentin and actin after a 4-h CO(2) pneumoperitoneum in the head-down position in rabbits with alpha-chymotrypsin-induced glaucoma.. Twenty-one rabbits with alpha-chymotrypsin-induced glaucoma in one eye received general anesthesia for 4 h in the head-down position and were randomly allocated to have (a) no pneumoperitoneum, (b) a 10 mmHg CO(2) pneumoperitoneum, or (c) a 20 mmHg CO(2) pneumoperitoneum. At the end of the trial, both the right glaucomatous and the left control eyes were enucleated and investigated immunocytochemically for alterations in vimentin and actin, and morphologically for retinal layer disorganization.. Except for the preexisting morphological changes induced by glaucoma, both the control and the glaucomatous eyes in all rabbits appeared normal in terms of retinal layer organization and the distribution of intracellular vimentin and actin whatever the intraperitoneal pressure level applied.. In rabbits with alpha-chymotrypsin-induced glaucoma, a 4-h CO(2) pneumoperitoneum of

Topics: Actins; Analysis of Variance; Animals; Biomarkers; Carbon Dioxide; Chymotrypsin; Glaucoma; Head-Down Tilt; Immunohistochemistry; Intraocular Pressure; Ischemia; Pneumoperitoneum, Artificial; Rabbits; Random Allocation; Retina; Retinal Vessels; Time Factors; Vimentin

Topics: Animals; Axonal Transport; Axons; Chymotrypsin; Electroretinography; Ganglia; Haplorhini; Intraocular Pressure; Ischemia; Leucine; Macaca; Nerve Tissue Proteins; Optic Nerve; Retina; Tritium

Topics: Amylases; Animals; Carboxypeptidases; Cats; Cholecystokinin; Chymotrypsin; Ischemia; Lipase; Pancreas; Pancreatic Juice; Secretin; Trypsin